Abstract
Developing new methods for chemotherapy drug delivery has become a topic of great concern. Vinca alkaloids are among the most widely used chemotherapy reagents for tumor therapy; however, their side effects are particularly problematic for many medical doctors. To reduce the toxicity and enhance the therapeutic efficiency of vinca alkaloids, many researchers have developed strategies such as using liposome-entrapped drugs, chemical- or peptide-modified drugs, polymeric packaging drugs, and chemotherapy drug combinations. This review mainly focuses on the development of a vinca alkaloid drug delivery system and the combination therapy. Five vinca alkaloids (eg, vincristine, vinblastine, vinorelbine, vindesine, and vinflunine) are reviewed.
Keywords: Vinca alkaloids, Drug delivery systems, Combination therapy, Vincristine, Vinblastine, Vinorelbine, Vindesine, Vinflunine, Vinpocetine.
Graphical Abstract
Current Topics in Medicinal Chemistry
Title:Drug Delivery Systems and Combination Therapy by Using Vinca Alkaloids
Volume: 15 Issue: 15
Author(s): Chun-Ting Lee, Yen-Wei Huang, Chih-Hui Yang and Keng-Shiang Huang
Affiliation:
Keywords: Vinca alkaloids, Drug delivery systems, Combination therapy, Vincristine, Vinblastine, Vinorelbine, Vindesine, Vinflunine, Vinpocetine.
Abstract: Developing new methods for chemotherapy drug delivery has become a topic of great concern. Vinca alkaloids are among the most widely used chemotherapy reagents for tumor therapy; however, their side effects are particularly problematic for many medical doctors. To reduce the toxicity and enhance the therapeutic efficiency of vinca alkaloids, many researchers have developed strategies such as using liposome-entrapped drugs, chemical- or peptide-modified drugs, polymeric packaging drugs, and chemotherapy drug combinations. This review mainly focuses on the development of a vinca alkaloid drug delivery system and the combination therapy. Five vinca alkaloids (eg, vincristine, vinblastine, vinorelbine, vindesine, and vinflunine) are reviewed.
Export Options
About this article
Cite this article as:
Lee Chun-Ting, Huang Yen-Wei, Yang Chih-Hui and Huang Keng-Shiang, Drug Delivery Systems and Combination Therapy by Using Vinca Alkaloids, Current Topics in Medicinal Chemistry 2015; 15 (15) . https://dx.doi.org/10.2174/1568026615666150414120547
DOI https://dx.doi.org/10.2174/1568026615666150414120547 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
miR-21, An Oncogenic Target miRNA for Cancer Therapy: Molecular Mechanisms and Recent Advancements in Chemo and Radio-resistance
Current Gene Therapy Chromatin Remodeling Agents for Cancer Therapy
Reviews on Recent Clinical Trials Are Selenoproteins Important for the Cancer Protective Effects of Selenium?
Current Nutrition & Food Science Immunotherapy: A Potential Approach to Targeting Cancer Stem Cells
Current Cancer Drug Targets Optimizing Gene Silencing Strategies for Pancreatic Cancer
Current Cancer Therapy Reviews Quantum Dot-Based Nanoprobes for In Vivo Targeted Imaging
Current Molecular Medicine Feud or Friend? The Role of the miR-17-92 Cluster in Tumorigenesis
Current Genomics Ototoxicity: Mechanisms of Cochlear Impairment and its Prevention
Current Medicinal Chemistry Development of NGR-Based Anti-Cancer Agents for Targeted Therapeutics and Imaging
Anti-Cancer Agents in Medicinal Chemistry Radionuclide Liver Cancer Therapies: From Concept to Current Clinical Status
Anti-Cancer Agents in Medicinal Chemistry Abatacept and Glomerular Diseases: The Open Road for the Second Signal as a New Target is Settled Down
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Combined Cancer Therapy with Non-Conventional Drugs: All Roads Lead to AMPK
Mini-Reviews in Medicinal Chemistry The Adenosine A2b Receptor: Its Role in Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Pharmacogenetic Aspects of Drug Metabolizing Enzymes in Busulfan Based Conditioning Prior to Allogenic Hematopoietic Stem Cell Transplantation in Children
Current Drug Metabolism Biology of PPARγ in Cancer: A Critical Review on Existing Lacunae
Current Molecular Medicine Cruciferous Plants: Phytochemical Toxicity Versus Cancer Chemoprotection
Mini-Reviews in Medicinal Chemistry Tumor Specific Imaging Using Tc-99m and Ga-68 Labeled Radiopharmaceuticals
Current Medical Imaging The Engaged Role of Tumor Microenvironment in Cancer Metabolism: Focusing on Cancer-Associated Fibroblast and Exosome Mediators
Anti-Cancer Agents in Medicinal Chemistry The Emerging Role of EMT-related lncRNAs in Therapy Resistance and their Applications as Biomarkers
Current Medicinal Chemistry The Application of Optical Technology in Microfluidic Systems
Current Proteomics